市場調查報告書
商品編碼
1190860
過濾器完整性測試市場——COVID-19 的增長、趨勢、影響和預測 (2023-2028)Filter Integrity Test Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
由於生物製藥行業的增長和研發活動支出的增加,預計過濾器完整性測試市場在預測期內的複合年增長率為 4.6%。
根據美國藥物研究與製造商協會 (PhRMA) 的數據,藥物開發通常需要 10-15 年時間,平均成本約為 26 億美元。 此外,2016 年,製藥和生物製藥公司的全球研發支出約為 1.567 億美元。 此外,2017 年,PhRMA 制定了一項新標準,要求每年至少平均投資約 2 億美元。 預計這些努力將推動對過濾器完整性測試的需求。
*在過濾器完整性測試市場,由於產品技術的出現及其對手動的主導地位,自動化部分有望成為主導部分。 手動過濾器測試儀完全依靠操作員來操作設備,因此難以維護記錄,而自動化則無需操作員參與,從而最大限度地減少或消除了污染。
*2019年,Sartorius AG開發了下游產品Sartocheck(R) 5 Plus Filter Integrity Tester。 可以檢測到人為錯誤、危險環境和不正確的測試設置。 Airtechnic International 還發布了 100X 自動過濾效率計,專為製藥製造中涉及的過濾介質和濾芯而設計。 因此,預計這些因素將推動這一特定領域的市場。
由於對製藥和生物製藥相關研發活動的投資不斷增加,預計北美地區將在全球過濾器完整性測試市場佔據主要市場份額。 根據 2016 年藥物研究與製造商協會 (PhRMA) 的數據,美國在研發支出中所佔比例很高,約為 58%。 此外,歐洲製藥工業協會聯合會發現,美國的研發支出約為 524.18 億美元。 因此,這些因素有望對過濾器完整性測試市場產生積極影響。
過濾器完整性測試市場是分散的,由幾家主要參與者組成。 目前主導該市場的公司包括 Merck KGaA、Sartorius AG、MEISSNER FILTRATION PRODUCTS INC、ThermoFisher Scientific Inc、Donaldson Company、PARKER HANNIFIN CORP、Eaton Corporation PLC、Pall Corporation、3M 和 Filter Integrity Ltd. increase。
The filter integrity test market is expected to register a CAGR of 4.6% during the forecast period, due to the growing biopharmaceutical industry and the increasing expenditure on R&D activities. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA), a drug development generally takes 10 to 15 years and it costs on an average of about USD 2.6 billion. Furthermore, in 2016, worldwide spending on R&D by the pharmaceutical and biopharmaceutical companies was around USD 156.7 million. Moreover, in 2017, PhRMA established new criteria according to which there should be a minimum average investment of about USD 200 million per year. Such initiatives are expected to drive the demand for a filter integrity test.
* The automated segment is expected to be a dominant segment in the filter integrity test market, owing to the developing technology in the product and its advantages over manual. It involves no operator, thus minimal or no contamination whereas in manual filter tester handling of the equipment is totally dependent on operators and maintenance of record becomes difficult.
* In 2019, Sartorius AG developed a product Sartocheck® 5 Plus filter integrity tester for downstream processing. It is able to detect human errors, hazardous environments, and improper test set-ups. Also, Air Techniques International introduced 100X Automated Filter Efficiency Tester designed for filter media and cartridges that are involved in pharmaceutical production. Thus, these factors are expected to propel the market in this particular segment.
The North American region is expected to hold a major market share in the global filter integrity test market, due to increasing investments in R&D activities related to pharmaceuticals and biopharmaceuticals. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA) data of 2016, United States has the highest share of around 58% in terms of R&D expenditure. Furthermore, according to the European Federation of Pharmaceutical Industries and Associations, the R&D expenditure was around 52,418 million USD in United States. Hence, these factors are expected to impact positively on the filter integrity test market.
The filter integrity test market is fragmented and consists of several major players. Some of the companies that are currently dominating the market are Merck KGaA, Sartorius AG, MEISSNER FILTRATION PRODUCTS INC., ThermoFisher Scientific Inc., Donaldson Company, PARKER HANNIFIN CORP., Eaton Corporation PLC, Pall Corporation, 3M, and Filter Integrity Ltd.